Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)
CNY 6.69
(-3.04%)
CNY 6.69
(-3.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -37.87 Million | -66.35 Million | 128.5 Million | 126.81 Million | 235.6 Million | 185.87 Million |
| Net Income | -151.49 Million | -195.74 Million | 65.9 Million | 160.07 Million | 201.59 Million | 182.7 Million |
| Depreciation & Amortization | 46.31 Million | 45.32 Million | 43.09 Million | 37.56 Million | 35.54 Million | 29.71 Million |
| Deferred income taxes | -308.1 Thousand | 6.65 Million | -2.51 Million | -985.27 Thousand | -721.79 Thousand | 607.26 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 27 Million | 50.13 Million | 12.3 Million | -96.29 Million | -10.44 Million | -21.88 Million |
| Other non-cash items | 7.4 Million | 33.93 Million | 7.19 Million | 25.46 Million | 8.9 Million | -4.65 Million |
| Investing Cash Flow | -51.89 Million | 131.54 Million | -432.84 Million | 127.84 Million | -11.82 Million | -75.16 Million |
| Investments in PPE | -23.13 Million | -42.83 Million | -54.81 Million | -61.95 Million | -10.86 Million | -173.69 Million |
| Acquisitions | 180.04 Thousand | 2.61 Million | 5752.21 | 72.8 Thousand | 200 Thousand | 0.51 |
| Investment purchases | -30 Million | -30 Million | -2 Million | -2 Million | -1.37 Billion | -100 Million |
| Sales/Maturities of investments | 15.61 Million | 15.93 Million | 18.72 Million | 24.72 Million | 20.84 Million | 23.53 Million |
| Other Investing Activities | -14.55 Million | 185.82 Million | -394.75 Million | 166.99 Million | 1.35 Billion | 175 Million |
| Financing Cash Flow | -158.98 Million | -473.34 Million | -278.89 Million | 811.92 Million | -427.92 Million | 284.84 Million |
| Debt repayment | -87.91 Million | -545 Million | -599.56 Million | -75 Million | -305 Million | -395 Million |
| Dividends payments | -8.08 Million | -71.76 Million | -142.68 Million | -101.92 Million | -265.72 Million | -106.01 Million |
| Common Stock Repurchased | -52.1 Million | -56.26 Million | - | - | - | - |
| Common Stock Issuance | - | 56.26 Million | - | - | - | - |
| Other Financing Activities | -62.99 Million | 151.78 Million | 479.88 Million | 999.91 Million | 156.38 Million | -4.13 Million |
| Accounts receivables | 4.8 Million | 46.63 Million | 42.64 Million | 62.65 Million | -58.17 Million | 28 Million |
| Accounts payables | 39.84 Million | -4.71 Million | -43.64 Million | -177.9 Million | 70.23 Million | -71.81 Million |
| Inventory | -17.33 Million | 1.54 Million | 15.82 Million | 19.94 Million | -21.77 Million | 21.31 Million |
| Other working capital | 39.53 Million | 6.65 Million | -2.51 Million | -985.27 Thousand | -721.79 Thousand | -43.2 Million |
| Cash at beginning of period | 563.21 Million | 971.37 Million | 1.55 Billion | 488.02 Million | 692.16 Million | 296.61 Million |
| Cash at end of period | 314.45 Million | 563.21 Million | 971.37 Million | 1.55 Billion | 488.02 Million | 692.16 Million |
| Capital Expenditure | -23.13 Million | -42.83 Million | -54.81 Million | -61.95 Million | -10.86 Million | -173.69 Million |
| Effect of forex changes on cash | 6.00 | 0.66 | - | 1.00 | 0.04 | - |
| Net cash flow / Change in cash | -248.76 Million | -408.15 Million | -583.23 Million | 1.06 Billion | -204.14 Million | 395.55 Million |
| Free Cash Flow | -61 Million | -109.19 Million | 73.68 Million | 64.86 Million | 224.73 Million | 12.17 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.48 Million | -24.35 Million | -16.04 Million | -151.49 Million | -54.91 Million | -26.86 Million |
| Depreciation & Amortization | - | 10.24 Million | 10.24 Million | 46.31 Million | 46.31 Million | -20.66 Million |
| Deferred income taxes | - | - | - | -308.1 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -5.18 Million | - | 27 Million | -12.53 Million | -14.02 Million |
| Other non-cash items | -18.24 Million | 18.26 Million | -4.3 Million | 7.4 Million | 4.4 Million | 68.61 Million |
| Investing Cash Flow | 53.88 Million | 47.69 Million | 80.88 Million | -51.89 Million | 37.76 Million | 42.6 Million |
| Investments in PPE | -1.11 Million | -3.68 Million | -4.11 Million | -23.13 Million | -2.2 Million | -4.78 Million |
| Acquisitions | 2300.00 | 1.91 Million | - | 180.04 Thousand | -25.65 Thousand | 2000.00 |
| Investment purchases | 2.53 Million | -2.53 Million | - | -30 Million | -1.03 Billion | 548 Million |
| Sales/Maturities of investments | -137 Million | 137 Million | 327.92 Thousand | 15.61 Million | 6.98 Million | 2.38 Million |
| Other Investing Activities | 189.46 Million | -85 Million | 85 Million | -14.55 Million | 33 Million | -503 Million |
| Financing Cash Flow | -223.91 Million | -327.76 Thousand | -90.04 Million | -158.98 Million | -154.86 Million | -803.77 Thousand |
| Debt repayment | -17.35 Million | - | -100 Million | -87.91 Million | -100.15 Million | -352.5 Thousand |
| Dividends payments | - | -68.73 Thousand | -127.57 Thousand | -8.08 Million | -5.16 Million | -904.94 Thousand |
| Common Stock Repurchased | 1.65 Million | -1.65 Million | - | -52.1 Million | -52.1 Million | 3.74 Million |
| Common Stock Issuance | - | - | - | - | - | -4.1 Million |
| Other Financing Activities | -208.21 Million | 1.85 Million | 9.95 Million | -62.99 Million | -49.54 Million | 806.17 Thousand |
| Accounts receivables | - | -24.36 Million | - | 4.8 Million | 4.8 Million | -14.14 Million |
| Accounts payables | - | - | - | 39.84 Million | - | - |
| Inventory | - | 19.25 Million | - | -17.33 Million | -17.33 Million | 120.33 Thousand |
| Other working capital | - | -70.97 Thousand | - | - | 398.81 Thousand | 398.81 Thousand |
| Cash at beginning of period | 323.67 Million | 296.1 Million | 474.87 Million | 563.21 Million | 448.27 Million | 401.8 Million |
| Cash at end of period | 123.22 Million | 323.67 Million | 296.1 Million | 314.45 Million | 314.45 Million | 448.27 Million |
| Capital Expenditure | -1.11 Million | -3.68 Million | -4.11 Million | -23.13 Million | -2.2 Million | -4.78 Million |
| Effect of forex changes on cash | - | - | -149.27 Million | 6.00 | 448.27 Million | -2.38 Million |
| Net cash flow / Change in cash | -200.44 Million | 27.57 Million | -178.77 Million | -248.76 Million | -133.82 Million | 46.47 Million |
| Free Cash Flow | -25.85 Million | -20.02 Million | -24.45 Million | -61 Million | -18.92 Million | 2.27 Million |
DOMO
RN70
4644
002457
WLDBF
603004